Author (Person) | Jack, Andrew |
---|---|
Series Title | Financial Times |
Series Details | 8.6.12 |
Publication Date | 08/06/2012 |
Content Type | News |
Major analysis feature. A ‘parallel trade’ in drugs pitches dealers against wholesalers and multinationals. While the trade in medicines, without the authorisation of the producer, to exploit price differences between countries is perfectly legal, it has come in for growing criticism for undermining innovation, patient health and affordable access to treatments. It has pitched the traders against pharmacists, wholesalers and multinational pharmaceutical groups. At stake in this cross-border 'parallel trade' is the tension between the fundamental principle of free movement of goods across the EU, enshrined in the treaty of Rome to encourage competition, and the exception of medicines prices, which are not freely set by companies but instead normally dictated by each national government. |
|
Related Links |
|
Subject Categories | Business and Industry, Internal Markets |
Countries / Regions | Europe |
![](https://www.europeansources.info/wp-content/uploads/esologo2.png)